Search

Displaying results 8241 - 8250 of 9323 in total
  1. Drug

    Ascrinvacumab

    go.drugbank.com/drugs/DB12261
    Investigational

    Ascrinvacumab has been used in trials studying the treatment and basic science of Neoplasms, Advanced Solid Tumors, Carcinoma, Hepatocellular, and Malignant Pleural Mesothelioma.

  2. Drug

    Sabarubicin

    go.drugbank.com/drugs/DB12410
    Investigational

    Sabarubicin has been used in trials studying the treatment of Prostate Cancer, Testicular Germ Cell Tumor, and Unspecified Adult Solid Tumor, Protocol Specific.

  3. Drug

    LY-295501

    go.drugbank.com/drugs/DB12574
    Investigational

    ILX-295501 has been used in trials studying the treatment of Ovarian Cancer, Metastatic Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cavity Cancer.

  4. Drug

    D-Tyrosine

    go.drugbank.com/drugs/DB03839
    Experimental

    It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin.

  5. Drug

    Trametes versicolor fruiting body

    go.drugbank.com/drugs/DB14287
    Investigational

    Trametes versicolor fruiting body is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  6. Drug

    Styphnolobium japonicum flower bud

    go.drugbank.com/drugs/DB14294
    Investigational

    Styphnolobium japonicum flower bud is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  7. Drug

    Camellia japonica seed oil

    go.drugbank.com/drugs/DB14308
    Investigational

    Camellia japonica seed oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  8. Drug

    Rosa centifolia flower oil

    go.drugbank.com/drugs/DB14363
    Investigational

    Rosa centifolia flower oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  9. Drug

    Osocimab

    go.drugbank.com/drugs/DB14818
    Investigational

    Osocimab is under investigation in clinical trial NCT03276143 (Factor XIa inhibition for the prevention of venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty).

  10. Drug

    Ethaselen

    go.drugbank.com/drugs/DB15051
    Investigational

    Ethaselen is under investigation in clinical trial NCT02166242 (Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers).